Adeniyi Ajenifuja, MD
Internal Medicine · Dover, DENPI 1164805982
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,279 of the $9,338 with a category attached, or 88.7%. It is spread thinly across 26 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,421, more than ten times the $14 reported in 2019. Among internal medicine clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $39.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novartis$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$892
- Abbott$801
- Boston Scientific$782
- ZOLL Circulation Inc$600
- plus $4K from 20 others
What the payments were for
- Food & beverage$8,27989%
- Education$1,05911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $1,056 |
| Novartis | 70 | $1,012 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 43 | $892 |
| Abbott | 4 | $801 |
| Boston Scientific | 12 | $782 |
| ZOLL Circulation Inc | 7 | $600 |
| Medtronic | 6 | $597 |
| Abiomed | 7 | $470 |
| Penumbra, Inc. | 5 | $454 |
| Heartflow, Inc. | 3 | $362 |
| Cvrx, Inc. | 7 | $298 |
| Shockwave Medical, Inc | 5 | $282 |
| Stryker | 1 | $231 |
| Kestra Medical Technology Services, Inc. | 10 | $229 |
| Pfizer | 6 | $227 |
| Edwards Lifesciences | 2 | $185 |
| Boehringer Ingelheim | 4 | $134 |
| Teleflex LLC | 1 | $128 |
| Lantheus Medical Imaging, Inc. | 1 | $107 |
| Chiesi USA, Inc. | 5 | $95 |
| Irhythm Technologies, Inc. | 1 | $90 |
| E.r. Squibb & Sons, L.L.C. | 1 | $78 |
| Johnson & Johnson | 2 | $70 |
| Cook Medical LLC | 1 | $58 |
| Amgen | 1 | $50 |
| Dexcom, Inc. | 2 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TherOx DS2 Console$509
- Catheter$509
- Downstream Cartridge$509
- ENSITE$508
- Indigo System$421
- FFRct$362
- CARDIOMEMS$293
- FlowTriever$231
- RESOLUTE ONYX$221
- COREVALVE EVOLUT R$200
- GENERAL VASCULAR ACCESS$196
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$142
- TURNPIKE$128
- VYNDAQEL$125
- WAINUA$125
- FARXIGA$125
- Impella$118
- WATCHMAN Access System$114
- EMBLEM MRI S-ICD$108
- Definity$107
How this compares
$9,338 in reported general payments places this provider in the 90th percentile of 477 internal medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $18,370 |
| BrilintaTicagrelor | 16 | $14,596 |
| Metoprolol Succinate | 36 | $348 |
| Atorvastatin Calcium | 29 | $327 |
| Rosuvastatin Calcium | 23 | $202 |
| ClopidogrelClopidogrel Bisulfate | 21 | $199 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $166 |
| Losartan Potassium | 12 | $113 |
| Amlodipine Besylate | 11 | $76 |
| Spironolactone | 17 | $75 |
| Lisinopril | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $227 | $18,37025 claims |
| AstraZenecaBrilinta | $1,056 | $14,59616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 477 internal medicine providers in Delaware.
Other internal medicine in Dover
- Natwarlal RamaniDover$10K
- Sandeep MannDover$6K
- Theodore Conrad TanDover$6K
- Abimbola OsunkoyaDover$5K
- Michael SweeneyDover$4K
- Vineet PuriDover$3K
- Seth IvinsNewark$384K
- Beshara HelouGeorgetown$143K
- Tabassum SalamNewark$62K
- Fabricio AlarconGeorgetown$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.